Explore the words cloud of the COCLICAN project. It provides you a very rough idea of what is the project "COCLICAN" about.
The following table provides information about the project.
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
|Coordinator Country||France [FR]|
|Total cost||450˙800 €|
|EC max contribution||450˙800 € (100%)|
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
|Duration (year-month-day)||from 2018-11-01 to 2021-10-31|
Take a look of project's partnership.
|1||INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT||FR (MARSEILLE)||coordinator||174˙800.00|
|2||UNIVERSITE PAUL SABATIER TOULOUSE III||FR (TOULOUSE CEDEX 9)||participant||96˙600.00|
|3||FONDATION MERIEUX||FR (LYON)||participant||55˙200.00|
|4||UNIVERSITE LIBRE DE BRUXELLES||BE (BRUXELLES)||participant||55˙200.00|
|5||ASSISTANCE PUBLIQUE HOPITAUX DE PARIS||FR (PARIS)||participant||36˙800.00|
|6||KAUNO TECHNOLOGIJOS UNIVERSITETAS||LT (KAUNAS)||participant||32˙200.00|
|7||INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-INEN||PE (LIMA)||partner||0.00|
|8||MINISTRY OF HEALTH||LA (LAO)||partner||0.00|
Hepatitis B (HBV) and C virus (HCV) are the most important etiologic agents of Hepatocellular carcinoma (HCC), which is the second leading cause of tumour related death in the world. The burden of HCC in developing countries represents a major challenge in global public health for the oncoming decades. Clinically, HCC patients have a very poor prognosis and high 5-year mortality rate except when detected early. As a result, HCC early detection is a critical parameter to anticipate the initiation of a tumour process, but affordable and discriminant diagnostic tools are lacking. A consortium of European and Third Countries institutions (Peru and Laos) gathered within the project COCLICAN proposes to tackle this issue through the analysis of metabolomics serum profiles of a large cohort of HBV-HBC infected patients to delineate a bunch of molecules predictive of the emergence of liver cancer. The performance of a low-cost and open-source echo-stethoscope connected to a smartphone will also be assessed, to allow early detection of tumorogenesis in health care underserved areas. This will be possible, thanks to the construction of a sustainable scientific and academic network of engineers, researchers and clinicians mobilised to exchange expertise, skills, technologies, biological material, deployed in three continents: Europe, South America and Asia. COCLICAN has been designed to improve research collaborations, to reinforce capacities, to enhance knowledge of partners and students involved in the project, but also to raise awareness of policy makers and to participate to the innovation potential improvement at the European and global levels. COCLICAN will therefore respond to the health needs of left behind populations, all around the world.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COCLICAN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "COCLICAN" are provided by the European Opendata Portal: CORDIS opendata.
Nonsmooth Contact DynamicsRead More
Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategyRead More
automatic detection and localization of High frequency Oscillation in Paediatric EpilepsyRead More